5th Microbiome Movement Drug Development Europe Conference

  • January 28, 2021 - January 29, 2021
  • Virtual Conference

Join us:

Biomica is delighted to participate at the 5th Microbiome Movement Drug Development Europe Conference, January 28-29, 2021 (Virtual Conference)

Dr. Haber , Biomica’s Chief Executive Officer, will be participating in the “European Microbiome Leaders” panel discussion, January 28th  9:00 AM

Dr. Shiri Meshner, VP R&D of Biomica, will be presenting: “From Computational Predictions to Preclinical Performance”, January 28th  3:30 PM

 

For more Details and Registration: https://microbiome-europe.com/whats-on/day-one/

 

View Biomica’s presentation at 5th Microbiome Movement Drug Development Europe Conference

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.